Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials

Publication | Closed Access

DOI

120

Citations

References

2005

Year

Joachim Drevs, Ute Zirrgiebel, C. Schmidt-Gersbach, K. Mross, Michael Medinger, L. Lee, José Cirı́aco Pinheiro, J M Wood, Anne Thomas, Clemens Unger,

Annals of Oncology

Tyrosine Kinase InhibitorMedicineReceptor Tyrosine KinasePharmacologySoluble MarkersColorectal CancerPathologyAdvanced Colorectal CancerOncologyTumor MicroenvironmentCancer Research